ArthroCare closes Opus merger:
This article was originally published in Clinica
ArthroCare, the Sunnyvale, California-based developer of Coblation technology, has completed its acquisition of Opus Medical. ArthroCare first announced its intention to buy the orthopaedic soft tissue repair systems developer in September (see Clinica No 1123, p 14) and has paid $30m in cash and $60m of ArthroCare stock up front. Further delayed and contingent payments will be made in 2005 and 2006.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.